In addition to not cross-reacting with other autoantibodies, anti-MAA antibody levels have been positively associated with other RA-related autoantibodies (RF, ACPA), disease activity (DAS28), and inflammatory markers (ESR, CRP) (21, 30, 31, 33, 38, 39). This evidence concerns the gene PRTN3 and rheumatoid arthritis.